Security key
89357L402
TransCode Therapeutics, Inc. - Common Stock, $0.0001 par value per share (RNAZ)
CUSIP: 89357L402
Q1 2025 13F Holders as of 31 Mar 2025
- Security type / class
- Equity / Common Stock, $0.0001 par value per share
- Total 13F shares
- 2,128,495
- Total 13F value
- $1,053,827
- Share change
- +2,118,585
- SEC-reported price per share
- $0.50
- Number of holders
- 15
- Value change
- +$1,048,922
- Number of buys
- 15
- Shares outstanding
- 1,028,000
Holder snapshot
5 signals
Security identity
Names, identifiers, and filing context for this profile.
1 source field
Report period
Q1 2025
Institutions
15
Top holders
10
RNAZ full security history
Ownership snapshot
Full 13F holder table
Transcode Therapeutics, Inc. SEC filings
Transcode Therapeutics, Inc. company facts
Broader feeds
Ownership snapshot
Top reported holders of RNAZ - TransCode Therapeutics, Inc. - Common Stock, $0.0001 par value per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Start with comparable ownership when available, then verify the linked 13F, 13D/G, or 3/4/5 evidence.
Comparable stake leader
SABBY MANAGEMENT, LLC
Disclosed value leader
Anna Moore
Comparable rows
2/13
Latest evidence
07 Mar 2025
13D/G
3/4/5
13F
Lead comparable stake: 9.9%
11 rows are not safely comparable across share classes.
13D/G row: SABBY MANAGEMENT, LLC
Showing 1-6 of 13 holder rows.
Quick read
SABBY MANAGEMENT, LLC leads the comparable SEC ownership view at 9.9%.
2 of 13 rows have a safely comparable ownership percentage. Use this as a filing-backed starting point, then open the detailed table for source links, reporting role, position value, share count, and filing date.
Open SEC evidence
Opens SABBY MANAGEMENT, LLC's linked filing trail.
Comparable ownership
Top 2
SABBY MANAGEMENT, LLC
9.9%
Thomas Joseph Tracy
5%
Ownership % is shown only when SEC disclosures are safely comparable across share classes.
Detailed SEC evidence table Showing 1-6 of 13 holder rows
| Holder | Evidence | Ownership % | Position | 12M Net Δ | As of |
|---|---|---|---|---|---|
| SABBY MANAGEMENT, LLC |
13D/G
|
9.9%
Reported 13D/G
· 31 Dec 2024
|
$26,431
69,555 shares
|
$0 | 31 Dec 2024 |
| Thomas Joseph Tracy |
13D/G
|
5%
Reported 13D/G
· 07 Mar 2025
|
$13,300
35,000 shares
|
$0 | 07 Mar 2025 |
| Anna Moore |
3/4/5
10%+ Owner
|
—
denominator unverified
|
$791,920
1,552,785 shares
|
— | 08 Jul 2021 |
| Zdravka Medarova |
3/4/5
Chief Technology Officer, 10%+ Owner
|
—
denominator unverified
|
—
60,000 shares
|
— | 12 Dec 2022 |
| Robert Michael Dudley |
3/4/5
Chief Executive Officer, Director
|
—
denominator unverified
|
$91,934
180,262 shares
|
— | 28 Sep 2023 |
| UBS Group AG |
13F
Company
|
—
denominator unverified
|
$29,238
8,676 shares
|
— | 31 Dec 2024 |
How to read this table
Rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
13F holder rows
Institutional holders as of Q1 2025
Investor-level positions for this CUSIP, loaded as an interactive table.
Institutions
15
Shares
2,128,495
Rows available
15
| Investor | Option | Weight % | Change % | SEC-reported value | * Price | Shares | Share Change | Activity | Report Period |
|---|
* SEC-reported price is the security price as of the portfolio date and can indicate the last known price at which the security was still held. The marker flags a reported price that did not pass the local price check.
Compare Q1 2025 vs Q1 2025 Across Filers
Q1 2025 holders
15
Q1 2025 holders
15
Holder diff
0
| Investor | Q1 2025 Shares | Q1 2025 Shares | Share Diff | Share Chg % | Q1 2025 value | Q1 2025 value | Value change | Value Chg % |
|---|